Sabra Healthcare REIT Inc (SBRA)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sabra Healthcare REIT Inc (SBRA) P/E Ratio & Valuation History
Sabra Healthcare REIT (SBRA) trades at 12.2x its 2026 FFO estimate. Its forward P/E is 32.1x. It trades at 5.7x sales and 1.8x book value. Its P/S is below its 5-year median of 5.8x.
Current Multiples
Its P/FFO of 12.2x uses the 2026 FFO estimate of $1.67 per share. Its enterprise value is 27.2x its EBITDA. Its free cash flow yield is 6.6%.
| Multiple | Value |
|---|---|
| P/FFO (2026 estimate) | 12.2x |
| P/E (trailing) | 18.8x |
| Forward P/E | 32.1x |
| Price to sales | 5.7x |
| Price to book | 1.8x |
| EV/EBITDA | 27.2x |
| Price to FCF | 15.2x |
| EV/FCF | 22.2x |
| PEG | 5.3 |
| FCF yield | 6.6% |
Historical Medians
Against its 10-year medians, its P/E is 23.0% below 24.4x, its P/S is 1.7% below 5.8x and its P/B is 63.6% above 1.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 18.8x | 29.6x | 24.4x |
| P/S | 5.7x | 5.8x | 5.8x |
| P/B | 1.8x | 1.2x | 1.1x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 15.3x in 2017 to 52.1x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $18.94 | 20.8x | 5.9x | 1.7x |
| 2024 | $17.32 | 28.4x | 5.8x | 1.5x |
| 2023 | $14.27 | 36.6x | 5.1x | 1.2x |
| 2022 | $12.43 | N/A | 5.5x | 0.9x |
| 2021 | $13.54 | 52.1x | 6.7x | 0.9x |
| 2020 | $17.37 | 23.8x | 6.1x | 1.1x |
| 2019 | $21.34 | 20.1x | 6.2x | 1.2x |
| 2018 | $16.48 | 22.3x | 4.7x | 0.9x |
| 2017 | $18.77 | 15.3x | 5.4x | 1.0x |
| 2016 | $24.42 | 27.1x | 6.0x | 1.6x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SBRA
What is SBRA's forward P/E ratio?
Sabra Healthcare REIT has a forward P/E ratio of 32.1x. It trades at 12.2x its 2026 FFO estimate.
Is SBRA stock overvalued?
Sabra Healthcare REIT trades at 12.2x its 2026 FFO estimate. GNG's valuation label for SBRA is Fairly valued.
What is SBRA's price to sales ratio?
Sabra Healthcare REIT has a price to sales ratio of 5.7x.
What is Sabra Healthcare REIT's average P/E ratio over 5 years?
Sabra Healthcare REIT's median P/E over the last 5 years is 29.6x, from 48 month-end values through Oct 2026. It trades at 12.2x its 2026 FFO estimate.
What is SBRA's PEG ratio?
Sabra Healthcare REIT has a PEG ratio of 5.3.
SBRA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors